<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               14 CLINICAL STUDIES<BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.1 Healing of Erosive Esophagitis<BR>                     <BR>                        The healing rates of NEXIUM 40 mg, NEXIUM 20 mg, and omeprazole 20 mg (the approved dose for this indication) were evaluated in patients with endoscopically diagnosed erosive esophagitis in four multicenter, double-blind, randomized studies. The healing rates at Weeks 4 and 8 were evaluated and are shown in the Table 9:<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="_RefID0E2QBI"><BR>                           <caption>Table 9: Erosive Esophagitis Healing Rate (Life-Table Analysis)</caption><BR>                           <col width="8%"/><BR>                           <col width="16%"/><BR>                           <col width="20%"/><BR>                           <col width="10%"/><BR>                           <col width="10%"/><BR>                           <col width="21%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph> Study</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>No. of Patients</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph> Treatment Groups</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph> Week 4</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph> Week 8</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>Significance Level <footnote ID="_RefFN1158779825-1">log-rank test vs. omeprazole 20 mg</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center"><BR>                                    <paragraph>1</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>588</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>NEXIUM 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>68.7%</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>90.6%</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>N.S.<footnote ID="_RefFN1158928327-1">N.S. = not significant (p &gt; 0.05)</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "/><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>588</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>69.5%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>88.3%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center"><BR>                                    <paragraph>2</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>654</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>75.9%</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>94.1%</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>p &lt; 0.001</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center"/><BR>                                 <td align="center"><BR>                                    <paragraph>656</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>NEXIUM 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>70.5%</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>89.9%</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>p &lt; 0.05</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "/><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>650</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>64.7%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>86.9%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center"><BR>                                    <paragraph>3</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>576</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>71.5%</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>92.2%</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>N.S.<footnoteRef IDREF="_RefFN1158928327-1"/><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "/><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>572</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>68.6%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>89.8%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center"><BR>                                    <paragraph>4</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>1216</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>81.7%</paragraph><BR>                                 </td><BR>                                 <td align="center"><BR>                                    <paragraph>93.7%</paragraph><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph>p &lt; 0.001</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "/><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>1209</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>68.7%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>84.2%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "/><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>In these same studies of patients with erosive esophagitis, sustained heartburn resolution and time to sustained heartburn resolution were evaluated and are shown in the Table 10:<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="_RefID0EHZBI"><BR>                           <caption>Table 10: Sustained Resolution<footnote ID="_RefFN1158780524-1">Defined as 7 consecutive days with no heartburn reported in daily patient diary.</footnote> of Heartburn (Erosive Esophagitis Patients)</caption><BR>                           <col width="8%"/><BR>                           <col width="16%"/><BR>                           <col width="20%"/><BR>                           <col width="23%"/><BR>                           <col width="23%"/><BR>                           <col width="21%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td styleCode="Botrule Lrule Toprule "/><BR>                                 <td styleCode="Botrule Lrule Toprule "/><BR>                                 <td styleCode="Botrule Lrule Toprule "/><BR>                                 <td colspan="2" styleCode="Botrule Lrule Toprule "><BR>                                    <paragraph>Cumulative Percent<footnote ID="_RefFN1158780390-1">Defined as the cumulative proportion of patients who have reached the start of sustained resolution</footnote> with Sustained Resolution</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Botrule Lrule Toprule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>Study</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>No. of Patients</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>Treatment Groups</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>Day 14</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>Day 28</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>Significance Level <footnote ID="_RefFN1158939502-1">log-rank test vs. omeprazole 20 mg</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>1</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>573</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>NEXIUM 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>64.3%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>72.7%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>N.S.<footnote ID="_RefFN1158929388-1">N.S. = not significant (p &gt; 0.05)</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "/><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>555</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>64.1%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>70.9%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>2</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>621</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>64.8%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>74.2%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>p &lt;0.001</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "/><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>620</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>NEXIUM 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>62.9%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>70.1%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>N.S.<footnoteRef IDREF="_RefFN1158929388-1"/><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "/><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>626</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>56.5%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>66.6%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>3</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>568</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>65.4%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>73.9%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>N.S.<footnoteRef IDREF="_RefFN1158929388-1"/><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "/><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>551</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>65.5%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>73.1%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>4</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>1187</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>67.6%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Botrule "><BR>                                    <paragraph>75.1%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>p &lt;0.001</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule Lrule "/><BR>                                 <td align="center" styleCode="Botrule Lrule "><BR>                                    <paragraph>1188</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule Lrule "><BR>                                    <paragraph>Omeprazole 20 mg</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule Lrule "><BR>                                    <paragraph>62.5%</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule Lrule "><BR>                                    <paragraph>70.8%</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Botrule Lrule "/><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>In these four studies, the range of median days to the start of sustained resolution (defined as 7 consecutive days with no heartburn) was 5 days for NEXIUM 40 mg, 7 to 8 days for NEXIUM 20 mg and 7 to 9 days for omeprazole 20 mg.<BR>                        There are no comparisons of 40 mg of NEXIUM with 40 mg of omeprazole in clinical trials assessing either healing or symptomatic relief of erosive esophagitis.<BR>                        <BR>                           Long-Term Maintenance of Healing of Erosive Esophagitis <BR>                        <BR>                        Two multicenter, randomized, double-blind placebo-controlled 4-arm trials were conducted in patients with endoscopically confirmed, healed erosive esophagitis to evaluate NEXIUM 40 mg (n=174), 20 mg (n=180), 10 mg (n=168) or placebo (n=171) once daily over six months of treatment. <BR>                        No additional clinical benefit was seen with NEXIUM 40 mg over NEXIUM 20 mg. <BR>                        The percentages of patients that maintained healing of erosive esophagitis at the various time points are shown in the Figures 2 and 3:<BR>                        <BR>                           Figure 2: Maintenance of Healing Rates by Month (Study 177)<BR>                        <BR>                        <BR>                        s= scheduled visit<BR>                        <BR>                           Figure 3: Maintenance of Healing Rates by Month (Study 178)<BR>                        <BR>                        <BR>                        s= scheduled visit<BR>                        Patients remained in remission significantly longer and the number of recurrences of erosive esophagitis was significantly less in patients treated with NEXIUM compared to placebo. <BR>                        In both studies, the proportion of patients on NEXIUM who remained in remission and were free of heartburn and other GERD symptoms was well differentiated from placebo.<BR>                        In a third multicenter open label study of 808 patients treated for 12 months with NEXIUM 40 mg, the percentage of patients that maintained healing of erosive esophagitis was 93.7% for six months and 89.4% for one year.<BR>                     <BR>                     <BR>                     <BR>                        <BR>                           Figure 2 Maintenance of Healing Rates by Month (Study 117)<BR>                           <BR>                              <BR>                           <BR>                        <BR>                     <BR>                     <BR>                        <BR>                           Figure 3 Maintenance of Healing Rates by Mondy (Study 178)<BR>                           <BR>                              <BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.2 Symptomatic Gastroesophageal Reflux Disease (GERD)<BR>                     <BR>                        Two multicenter, randomized, double-blind, placebo-controlled studies were conducted in a total of 717 patients comparing four weeks of treatment with NEXIUM 20 mg or 40 mg once daily versus placebo for resolution of GERD symptoms. Patients had ≥ 6-month history of heartburn episodes, no erosive esophagitis by endoscopy, and heartburn on at least four of the seven days immediately preceding randomization.<BR>                        The percentage of patients that were symptom-free of heartburn was significantly higher in the NEXIUM groups compared to placebo at all follow-up visits (Weeks 1, 2, and 4). <BR>                        No additional clinical benefit was seen with NEXIUM 40 mg over NEXIUM 20 mg. <BR>                        The percent of patients symptom-free of heartburn by day are shown in the Figures 4 and 5:<BR>                        <BR>                           Figure 4: Percent of Patients Symptom-Free of Heartburn by Day (Study 225)<BR>                        <BR>                        <BR>                        <BR>                           Figure 5: Percent of Patients Symptom-Free of Heartburn by Day (Study 226)<BR>                        <BR>                        <BR>                        In three European symptomatic GERD trials, NEXIUM 20 mg and 40 mg and omeprazole 20 mg were evaluated. No significant treatment related differences were seen.<BR>                     <BR>                     <BR>                     <BR>                        <BR>                           Figure 4 Percent of Patients Symptom-Free of Heartburn by Day (Study 225)<BR>                           <BR>                              <BR>                           <BR>                        <BR>                     <BR>                     <BR>                        <BR>                           Figure 5 Percent of Patients Symptom-Free of Heartburn by Day (Study 226)<BR>                           <BR>                              <BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.3 Pediatric Gastroesophageal Reflux Disease (GERD)<BR>                     <BR>                        <BR>                           1 to 11 Years of Age<BR>                        <BR>                        In a multicenter, parallel-group study, 109 pediatric patients with a history of endoscopically-proven GERD (1 to 11 years of age; 53 female; 89 Caucasian, 19 Black, 1 Other) were treated with NEXIUM once daily for up to 8 weeks to evaluate safety and tolerability. Dosing by patient weight was as follows:<BR>                        <BR>                           <BR>                               weight < 20 kg: once daily treatment with NEXIUM 5 mg or 10 mg  <BR>                           <BR>                               weight ≥ 20 kg: once daily treatment with NEXIUM 10 mg or 20 mg  <BR>                        <BR>                        Patients were endoscopically characterized as to the presence or absence of erosive esophagitis.  <BR>                        Of the 109 patients, 53 had erosive esophagitis at baseline (51 had mild, 1 moderate, and 1 severe esophagitis). Although most of the patients who had a follow up endoscopy at the end of 8 weeks of treatment healed, spontaneous healing cannot be ruled out because these patients had low grade erosive esophagitis prior to treatment, and the trial did not include a concomitant control.<BR>                        <BR>                           12 to 17 Years of Age <BR>                        <BR>                        In a multicenter, randomized, double-blind, parallel-group study, 149 adolescent patients (12 to 17 years of age; 89 female; 124 Caucasian, 15 Black, 10 Other) with clinically diagnosed GERD were treated with either NEXIUM 20 mg or NEXIUM 40 mg once daily for up to 8 weeks to evaluate safety and tolerability.  Patients were not endoscopically characterized as to the presence or absence of erosive esophagitis.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.4 Risk Reduction of NSAID-Associated Gastric Ulcer<BR>                     <BR>                        Two multicenter, double-blind, placebo-controlled studies were conducted in patients at risk of developing gastric and/or duodenal ulcers associated with continuous use of non-selective and COX-2 selective NSAIDs.  A total of 1429 patients were randomized across the 2 studies.  Patients ranged in age from 19 to 89 (median age 66.0 years) with 70.7% female, 29.3% male, 82.9% Caucasian, 5.5% Black, 3.7% Asian, and 8.0% Others.  At baseline, the patients in these studies were endoscopically confirmed not to have ulcers but were determined to be at risk for ulcer occurrence due to their age (≥60 years) and/or history of a documented gastric or duodenal ulcer within the past 5 years.  Patients receiving NSAIDs and treated with NEXIUM 20 mg or 40 mg once-a-day experienced significant reduction in gastric ulcer occurrences relative to placebo treatment at 26 weeks.  See Table 11. No additional benefit was seen with NEXIUM 40 mg over NEXIUM 20 mg. These studies did not demonstrate significant reduction in the development of NSAID-associated duodenal ulcer due to the low incidence.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="_RefID0ESGCI"><BR>                           <caption> Table 11: Cumulative percentage of patients without gastric ulcers at 26 weeks:</caption><BR>                           <col width="8%"/><BR>                           <col width="16%"/><BR>                           <col width="18%"/><BR>                           <col width="44%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td styleCode="Botrule Lrule Toprule "><BR>                                    <paragraph>Study</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule Lrule Toprule "><BR>                                    <paragraph>No. of Patients</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule Lrule Toprule "><BR>                                    <paragraph>Treatment Group</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Botrule Lrule Toprule "><BR>                                    <paragraph>% of Patients Remaining Gastric Ulcer Free<footnote ID="_RefFN1158780669-1">%= Life Table Estimate. Significant difference from placebo (p&lt;0.01).</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>1</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>191</paragraph><BR>                                    <paragraph>194</paragraph><BR>                                    <paragraph>184</paragraph><BR>                                 </td><BR>                                 <td styleCode="Lrule Botrule "><BR>                                    <paragraph>NEXIUM 20 mg</paragraph><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                    <paragraph>Placebo</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>95.4</paragraph><BR>                                    <paragraph>96.7</paragraph><BR>                                    <paragraph>88.2</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Botrule Lrule "><BR>                                    <paragraph>2</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule Lrule "><BR>                                    <paragraph>267</paragraph><BR>                                    <paragraph>271</paragraph><BR>                                    <paragraph>257</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule Lrule "><BR>                                    <paragraph>NEXIUM 20 mg</paragraph><BR>                                    <paragraph>NEXIUM 40 mg</paragraph><BR>                                    <paragraph>Placebo</paragraph><BR>                                 </td><BR>                                 <td styleCode="Rrule Botrule Lrule "><BR>                                    <paragraph>94.7</paragraph><BR>                                    <paragraph>95.3</paragraph><BR>                                    <paragraph>83.3</paragraph><BR>                                 </td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                     <BR><BR><BR><BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.5 Helicobacter pylori (H.pylori) Eradication in Patients with Duodenal Ulcer Disease<BR>                     <BR>                        <BR>                           Triple Therapy (NEXIUM/amoxicillin/clarithromycin): Two multicenter, randomized, double-blind studies were conducted using a 10 day treatment regimen. The first study (191) compared NEXIUM 40 mg once daily in combination with amoxicillin 1000 mg twice daily and clarithromycin 500 mg twice daily to NEXIUM 40 mg once daily plus clarithromycin 500 mg twice daily. The second study (193) compared NEXIUM 40 mg once daily in combination with amoxicillin 1000 mg twice daily and clarithromycin 500 mg twice daily to NEXIUM 40 mg once daily. H. pylori eradication rates, defined as at least two negative tests and no positive tests from CLOtest®, histology and/or culture, at 4 weeks post-therapy were significantly higher in the NEXIUM plus amoxicillin and clarithromycin group than in the NEXIUM plus clarithromycin or NEXIUM alone group. The results are shown in Table 12:<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="_RefID0EYJCI"><BR>                           <caption>Table 12: H. pylori Eradication Rates at 4 Weeks after 10 Day Treatment Regimen % of Patients Cured [95% Confidence Interval] (Number of Patients)</caption><BR>                           <col width="8%"/><BR>                           <col width="45%"/><BR>                           <col width="15%"/><BR>                           <col width="17%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>Study</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>Treatment Group</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>Per-Protocol<footnote ID="_Ref338392934">Patients were included in the analysis if they had H. pylori infection documented at baseline, had at least one endoscopically verified duodenal ulcer &#8805; 0.5 cm in diameter at baseline or had a documented history of duodenal ulcer disease within the past 5 years, and were not protocol violators.  Patients who dropped out of the study due to an adverse reaction related to the study drug were included in the analysis as not H. pylori eradicated.</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>Intent-to-Treat<footnote ID="_Ref338393167">Patients were included in the analysis if they had documented H. pylori infection at baseline, had at least one documented duodenal ulcer at baseline, or had a documented history of duodenal ulcer disease, and took at least one dose of study medication.  All dropouts were included as not H. pylori eradicated.</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>191</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>NEXIUM plus amoxicillin and clarithromycin </paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>84%<footnote ID="_Ref338393337"> p &lt; 0.05 compared to NEXIUM plus clarithromycin.</footnote><BR>                                    </paragraph><BR>                                    <paragraph>[78, 89]</paragraph><BR>                                    <paragraph>(n=196)</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>77%<footnoteRef IDREF="_Ref338393337"/><BR>                                    </paragraph><BR>                                    <paragraph>[71, 82]</paragraph><BR>                                    <paragraph>(n=233)</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "/><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>NEXIUM plus clarithromycin</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>55%</paragraph><BR>                                    <paragraph>[48, 62]</paragraph><BR>                                    <paragraph>(n=187)</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>52%</paragraph><BR>                                    <paragraph>[45, 59]</paragraph><BR>                                    <paragraph>(n=215)</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>193</paragraph><BR>                                 </td><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>NEXIUM plus amoxicillin and clarithromycin </paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>85%<footnote ID="_Ref338393384"> p &lt; 0.05 compared to NEXIUM alone.</footnote><BR>                                    </paragraph><BR>                                    <paragraph>[74, 93]</paragraph><BR>                                    <paragraph>(n=67)</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>78%<footnoteRef IDREF="_Ref338393384"/><BR>                                    </paragraph><BR>                                    <paragraph>[67, 87]</paragraph><BR>                                    <paragraph>(n=74)</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Botrule "/><BR>                                 <td styleCode="Botrule "><BR>                                    <paragraph>NEXIUM</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>5%</paragraph><BR>                                    <paragraph>[0, 23]</paragraph><BR>                                    <paragraph>(n=22)</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Botrule "><BR>                                    <paragraph>4%</paragraph><BR>                                    <paragraph>[0, 21]</paragraph><BR>                                    <paragraph>(n=24)</paragraph><BR>                                 </td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>The percentage of patients with a healed baseline duodenal ulcer by 4 weeks after the 10 day treatment regimen in the NEXIUM plus amoxicillin and clarithromycin group was 75% (n=156) and 57% (n=60) respectively, in the 191 and 193 studies (per-protocol analysis). <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.6 Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome<BR>                     <BR>                        In a multicenter, open-label dose-escalation study of 21 patients (15 males and 6 females, 18 Caucasian and 3 Black, mean age of 55.5 years) with pathological hypersecretory conditions, such as Zollinger-Ellison Syndrome, NEXIUM significantly inhibited gastric acid secretion.  Initial dose was 40 mg twice daily in 19/21 patients and 80 mg twice daily in 2/21 patients. Total daily doses ranging from 80 mg to 240 mg for 12 months maintained gastric acid output below the target levels of 10 mEq/h in patients without prior gastric acid-reducing surgery and below 5 mEq/hr in patients with prior gastric acid-reducing surgery.  At the Month 12 final visit, 18/20 (90%) patients had Basal Acid Output (BAO) under satisfactory control (median BAO = 0.17 mmol/hr). Of the 18 patients evaluated with a starting dose of 40 mg twice daily, 13 (72%) had their BAO controlled with the original dosing regimen at the final visit. See Table 13.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="_RefID0EWOCI"><BR>                           <caption>Table 13: Adequate Acid Suppression at Final Visit by Dose Regimen</caption><BR>                           <col width="36%"/><BR>                           <col width="57%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule "><BR>                                    <paragraph>NEXIUM dose at the Month 12 visit</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule "><BR>                                    <paragraph>BAO under adequate control at the Month 12 visit (N=20)<footnote ID="_Ref338327759">One patient was not evaluated.</footnote><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>40 mg twice daily</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule "><BR>                                    <paragraph>13/15</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Rrule Lrule Botrule "><BR>                                    <paragraph>80 mg twice daily</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule "><BR>                                    <paragraph>4/4</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule "><BR>                                    <paragraph>80 mg three times daily</paragraph><BR>                                 </td><BR>                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule "><BR>                                    <paragraph>1/1</paragraph><BR>                                 </td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                     <BR><BR><BR><BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>